Bausch & Lomb (stylized as Bausch + Lomb since 2010) is an eye health products company based in Vaughan, Ontario. It produces contacts and intraocular lenses, medications, and eye surgery-related products.
| trading_symbol | registrant_name | time | price | change | percentage_change |
|---|---|---|---|---|---|
| BLCO | Bausch & Lomb Corp | 2026-11-02 12:00:54 | 20.04 | 0.05 | 0.28 |
| trading_symbol | central_index_key | registrant_name | isin_number | lei_number | ein_number | exchange | sic_code | sic_description | fiscal_year_end | state_of_incorporation | address_street | address_city | address_state | address_zip_code | address_country | address_country_code | phone_number | mailing_address | business_address | former_name | industry | founding_date | chief_executive_officer | number_of_employees | website | market_cap | shares_issued | shares_outstanding | description | update_time |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BLCO | 0001860742 | Bausch & Lomb Corp | CA0717051076 | — | — | NYSE | 3851 | Ophthalmic Goods | 1231 | — | 520 APPLEWOOD CRESCENT | VAUGHAN | A6 | L4K 4B4 | CANADA | CA | 908-541-5456 | 520 APPLEWOOD CRESCENT, VAUGHAN, A6, L4K 4B4 | 520 APPLEWOOD CRESCENT, VAUGHAN, A6, L4K 4B4 | — | Medical instruments | 1853 | Brent Saunders | 12,900 | http://bausch.com | 556,990,755 | 357,385,394 | 357,497,374 | Bausch & Lomb (stylized as Bausch + Lomb since 2010) is an eye health products company based in Vaughan, Ontario. It produces contacts and intraocular lenses, medications, and eye surgery-related products. | 2026-10-30 01:59:20 |
| Fiscal Year | Market Cap | Change In Market Cap | Percentage Change In Market Cap | Shares Outstanding | Change In Shares Outstanding | Percentage Change In Shares Outstanding |
|---|---|---|---|---|---|---|
| 2025 | 556,990,755 | -41,102,797 | -6.8723 | 354,318,198 | 1,847,402 | 0.5241 |
| 2024 | 598,093,552 | -204,219,630 | -25.4539 | 352,470,796 | 1,478,553 | 0.4212 |
| 2023 | 802,313,182 | 199,565,741 | 33.1093 | 350,992,243 | 991,310 | 0.2832 |
| Fiscal Year | Employee Count |
|---|---|
| 2025 | 13,000 |
| 2024 | 13,500 |
| 2023 | 13,300 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Revenue | 5,101,000,000 | 4,791,000,000 | 4,146,000,000 |
| Cost Of Revenue | — | — | — |
| Gross Profit | 5,101,000,000 | 4,791,000,000 | 4,146,000,000 |
| Research And Development Expenses | 371,000,000 | 343,000,000 | 324,000,000 |
| General And Administrative Expenses | 2,234,000,000 | 2,082,000,000 | 1,736,000,000 |
| Operating Expenses | 4,988,000,000 | 4,629,000,000 | 4,016,000,000 |
| Operating Income | 113,000,000 | 162,000,000 | 130,000,000 |
| Net Income | -360,000,000 | -317,000,000 | -260,000,000 |
| Earnings Per Share Basic | -1.02 | -0.9 | -0.74 |
| Earnings Per Share Diluted | -1.02 | -0.9 | -0.74 |
| Weighted Average Shares Outstanding Basic | 353,800,000 | 351,800,000 | 350,500,000 |
| Weighted Average Shares Outstanding Diluted | 353,800,000 | 351,800,000 | 350,500,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Cash And Cash Equivalents | 383,000,000 | 305,000,000 | 331,000,000 |
| Marketable Securities Current | — | — | — |
| Accounts Receivable | 1,221,000,000 | 1,026,000,000 | 839,000,000 |
| Inventories | 976,000,000 | 1,036,000,000 | 1,028,000,000 |
| Non Trade Receivables | — | — | — |
| Other Assets Current | 383,000,000 | 410,000,000 | 541,000,000 |
| Total Assets Current | 2,977,000,000 | 2,788,000,000 | 2,742,000,000 |
| Marketable Securities Non Current | — | — | — |
| Property Plant And Equipment | 1,762,000,000 | 1,485,000,000 | 1,390,000,000 |
| Other Assets Non Current | 310,000,000 | 294,000,000 | 225,000,000 |
| Total Assets Non Current | 1,762,000,000 | 1,485,000,000 | 1,390,000,000 |
| Total Assets | 14,022,000,000 | 13,469,000,000 | 13,442,000,000 |
| Accounts Payable | 388,000,000 | 389,000,000 | 522,000,000 |
| Deferred Revenue | — | — | — |
| Short Term Debt | 28,000,000 | 40,000,000 | 30,000,000 |
| Other Liabilities Current | 1,493,000,000 | 1,309,000,000 | 1,027,000,000 |
| Total Liabilities Current | 1,920,000,000 | 1,738,000,000 | 1,579,000,000 |
| Long Term Debt | 5,048,000,000 | 4,784,000,000 | 4,562,000,000 |
| Other Liabilities Non Current | 521,000,000 | 430,000,000 | 397,000,000 |
| Total Liabilities Non Current | 5,583,000,000 | 5,187,000,000 | 4,943,000,000 |
| Total Liabilities | 7,503,000,000 | 6,925,000,000 | 6,522,000,000 |
| Common Stock | 0 | 0 | 0 |
| Retained Earnings | -931,000,000 | -571,000,000 | -254,000,000 |
| Accumulated Other Comprehensive Income | -1,184,000,000 | -1,385,000,000 | -1,245,000,000 |
| Total Shareholders Equity | 6,448,000,000 | 6,473,000,000 | 6,850,000,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Depreciation And Amortization | 421,000,000 | 436,000,000 | 382,000,000 |
| Share Based Compensation Expense | 149,000,000 | 92,000,000 | 74,000,000 |
| Other Non Cash Income Expense | -3,000,000 | 19,000,000 | 3,000,000 |
| Change In Accounts Receivable | 148,000,000 | 227,000,000 | 121,000,000 |
| Change In Inventories | -38,000,000 | 147,000,000 | 264,000,000 |
| Change In Non Trade Receivables | — | — | — |
| Change In Other Assets | -20,000,000 | -161,000,000 | 147,000,000 |
| Change In Accounts Payable | 108,000,000 | 126,000,000 | 245,000,000 |
| Change In Other Liabilities | — | — | — |
| Cash From Operating Activities | 283,000,000 | 232,000,000 | -17,000,000 |
| Purchases Of Marketable Securities | 11,000,000 | 12,000,000 | 17,000,000 |
| Sales Of Marketable Securities | 8,000,000 | 14,000,000 | 16,000,000 |
| Acquisition Of Property Plant And Equipment | 349,000,000 | 291,000,000 | 181,000,000 |
| Acquisition Of Business | 7,000,000 | 4,000,000 | 25,000,000 |
| Other Investing Activities | 122,000,000 | 138,000,000 | 1,941,000,000 |
| Cash From Investing Activities | -455,000,000 | -412,000,000 | -2,109,000,000 |
| Tax Withholding For Share Based Compensation | 15,000,000 | 12,000,000 | 10,000,000 |
| Payments Of Dividends | — | — | — |
| Issuance Of Common Stock | — | — | — |
| Repurchase Of Common Stock | — | — | — |
| Issuance Of Long Term Debt | 3,357,000,000 | 631,000,000 | 2,276,000,000 |
| Repayment Of Long Term Debt | 3,096,000,000 | 430,000,000 | 161,000,000 |
| Other Financing Activities | 0 | -1,000,000 | -2,000,000 |
| Cash From Financing Activities | 225,000,000 | 178,000,000 | 2,078,000,000 |
| Change In Cash | 81,000,000 | -18,000,000 | -46,000,000 |
| Cash At End Of Period | 383,000,000 | 305,000,000 | 331,000,000 |
| Income Taxes Paid | 59,000,000 | 91,000,000 | 64,000,000 |
| Interest Paid | 380,000,000 | 415,000,000 | 238,000,000 |
| Fiscal Year | 2025 | 2024 | 2023 |
|---|---|---|---|
| Earnings Per Share | -1.02 | -0.9 | -0.74 |
| Price To Earnings Ratio | -16.7451 | -20.0667 | -23.0541 |
| Earnings Growth Rate | 13.3333 | 21.6216 | -3,800 |
| Price Earnings To Growth Ratio | -1.2559 | -0.9281 | 0.0061 |
| Book Value Per Share | 18.4257 | 18.6015 | 19.7432 |
| Price To Book Ratio | 0.927 | 0.9709 | 0.8641 |
| Ebitda | 541,000,000 | 609,000,000 | 469,000,000 |
| Enterprise Value | 10,735,904,000 | 10,872,508,000 | 10,240,530,000 |
| Dividend Yield | — | — | — |
| Dividend Payout Ratio | — | — | — |
| Debt To Equity Ratio | 0.7872 | 0.7452 | 0.6704 |
| Capital Expenditures | 698,000,000 | 531,000,000 | 472,000,000 |
| Free Cash Flow | -415,000,000 | -299,000,000 | -489,000,000 |
| Return On Equity | -0.0558 | -0.049 | -0.038 |
| One Year Beta | 1.2645 | 0.9204 | 0.9395 |
| Three Year Beta | 1.1055 | 0.9933 | 1.0144 |
| Five Year Beta | 1.0837 | 0.9933 | 1.0144 |
| Insider Name | Relationship To Issuer | Transaction Date | Amount Of Securities | Acquired Or Disposed | Securities Owned Following Transaction |
|---|---|---|---|---|---|
| Chersi Robert J | Director | 2026-08-12 | 11,776 | A | 11,776 |
| PAUL LAURENCE E | Director | 2026-08-12 | 11,776 | A | 11,776 |
| Trebbi Barbara | Director | 2026-08-12 | 11,776 | A | 11,776 |
| Munsch Frederick | SVP, Controller and CAO | 2026-08-10 | 52,900 | D | 45,831 |
| VON ESCHENBACH ANDREW C. | Director | 2026-08-07 | 6,059 | D | 63,733 |
| Investor Name | Period Of Report | Market Value | Amount Of Securities | Price Per Security |
|---|---|---|---|---|
| Provenance Wealth Advisors, LLC | 2026-09-30 | 2,805 | 165 | 17 |
| Bell Investment Advisors, Inc | 2026-09-30 | 510 | 30 | 17 |
| State of Wyoming | 2026-09-30 | 234,124 | 13,772 | 17 |
| Verdence Capital Advisors LLC | 2026-09-30 | 686,273 | 40,369 | 17 |
| Beach Point Capital Management LP | 2026-09-30 | 5,882,323 | 346,019 | 17 |
| Registrant Name | Period Of Report | Fund Name | Fund Symbol | Amount Of Units | Value In Usd | Percentage Value Compared To Assets |
|---|---|---|---|---|---|---|
| T. Rowe Price Credit Opportunities Fund, Inc. | 2026-08-31 | T. Rowe Price Credit Opportunities Fund-I Class | TCRRX | 52,900 | 924,692 | 0.2276 |
| T. Rowe Price Credit Opportunities Fund, Inc. | 2026-08-31 | T. Rowe Price Credit Opportunities Fund-Advisor Class | PAOPX | 52,900 | 924,692 | 0.2276 |
| T. Rowe Price Credit Opportunities Fund, Inc. | 2026-08-31 | T. Rowe Price Credit Opportunities Fund, Inc. | PRCPX | 52,900 | 924,692 | 0.2276 |
| T. Rowe Price Institutional Income Funds, Inc. | 2026-08-31 | T. Rowe Price Institutional High Yield Fund | TRHYX | 218,211 | 3,814,328.28 | 0.2294 |
| T. Rowe Price High Yield Fund, Inc. | 2026-08-31 | T. Rowe Price High Yield Fund-Z Class | TRKZX | 837,050 | 14,631,634 | 0.2268 |